A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity

The latest advancements in oncology research are focused on autologous immune cell therapy. However, the effectiveness of this type of immunotherapy for cancer remediation is not equivalent for all patients or cancer types. This suggests the need for better preclinical screening models that more clo...

Full description

Bibliographic Details
Main Authors: Hilary Sherman, Hannah J. Gitschier, Ann E. Rossi
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00857/full
_version_ 1818595512545181696
author Hilary Sherman
Hannah J. Gitschier
Ann E. Rossi
author_facet Hilary Sherman
Hannah J. Gitschier
Ann E. Rossi
author_sort Hilary Sherman
collection DOAJ
description The latest advancements in oncology research are focused on autologous immune cell therapy. However, the effectiveness of this type of immunotherapy for cancer remediation is not equivalent for all patients or cancer types. This suggests the need for better preclinical screening models that more closely recapitulate in vivo tumor biology. The established method for investigating tumoricidal activity of immunotherapies has been study of two-dimensional (2D) monolayer cultures of immortalized cancer cell lines or primary tumor cells in standard tissue culture vessels. Indeed, a proven means to examine immune cell migration and invasion are 2D chemotaxis assays in permeabilized supports or Boyden chambers. Nevertheless, the more in vivo-like three-dimensional (3D) multicellular tumor spheroids are quickly becoming the favored model to examine immune cell invasion and tumor cell cytotoxicity. Accordingly, we have developed a 3D immune oncology model by combining 96-well permeable support systems and 96-well low-attachment microplates. The use of the permeable support system enables assessment of immune cell migration, which was tested in this study as chemotactic response of natural killer NK-92MI cells to human stromal-cell derived factor-1 (SDF-1α). Immune invasion was assessed by measuring NK-92MI infiltration into lung carcinoma A549 cell spheroids that were formed in low-attachment microplates. The novel pairing of the permeable support system with low-attachment microplates permitted simultaneous investigation of immune cell homing, immune invasion of tumor spheroids, and spheroid cytotoxicity. In effect, the system represents a more comprehensive and in vivo-like immune oncology model that can be utilized for high-throughput study of tumoricidal activity.
first_indexed 2024-12-16T11:17:12Z
format Article
id doaj.art-aa48d29ab70e44368919ffb6f5f56841
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-16T11:17:12Z
publishDate 2018-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-aa48d29ab70e44368919ffb6f5f568412022-12-21T22:33:34ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-04-01910.3389/fimmu.2018.00857336919A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal ActivityHilary ShermanHannah J. GitschierAnn E. RossiThe latest advancements in oncology research are focused on autologous immune cell therapy. However, the effectiveness of this type of immunotherapy for cancer remediation is not equivalent for all patients or cancer types. This suggests the need for better preclinical screening models that more closely recapitulate in vivo tumor biology. The established method for investigating tumoricidal activity of immunotherapies has been study of two-dimensional (2D) monolayer cultures of immortalized cancer cell lines or primary tumor cells in standard tissue culture vessels. Indeed, a proven means to examine immune cell migration and invasion are 2D chemotaxis assays in permeabilized supports or Boyden chambers. Nevertheless, the more in vivo-like three-dimensional (3D) multicellular tumor spheroids are quickly becoming the favored model to examine immune cell invasion and tumor cell cytotoxicity. Accordingly, we have developed a 3D immune oncology model by combining 96-well permeable support systems and 96-well low-attachment microplates. The use of the permeable support system enables assessment of immune cell migration, which was tested in this study as chemotactic response of natural killer NK-92MI cells to human stromal-cell derived factor-1 (SDF-1α). Immune invasion was assessed by measuring NK-92MI infiltration into lung carcinoma A549 cell spheroids that were formed in low-attachment microplates. The novel pairing of the permeable support system with low-attachment microplates permitted simultaneous investigation of immune cell homing, immune invasion of tumor spheroids, and spheroid cytotoxicity. In effect, the system represents a more comprehensive and in vivo-like immune oncology model that can be utilized for high-throughput study of tumoricidal activity.http://journal.frontiersin.org/article/10.3389/fimmu.2018.00857/fullcancerimmune cell invasionimmune cell infiltrationimmune cell migrationimmune oncologyspheroid
spellingShingle Hilary Sherman
Hannah J. Gitschier
Ann E. Rossi
A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
Frontiers in Immunology
cancer
immune cell invasion
immune cell infiltration
immune cell migration
immune oncology
spheroid
title A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
title_full A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
title_fullStr A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
title_full_unstemmed A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
title_short A Novel Three-Dimensional Immune Oncology Model for High-Throughput Testing of Tumoricidal Activity
title_sort novel three dimensional immune oncology model for high throughput testing of tumoricidal activity
topic cancer
immune cell invasion
immune cell infiltration
immune cell migration
immune oncology
spheroid
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.00857/full
work_keys_str_mv AT hilarysherman anovelthreedimensionalimmuneoncologymodelforhighthroughputtestingoftumoricidalactivity
AT hannahjgitschier anovelthreedimensionalimmuneoncologymodelforhighthroughputtestingoftumoricidalactivity
AT annerossi anovelthreedimensionalimmuneoncologymodelforhighthroughputtestingoftumoricidalactivity
AT hilarysherman novelthreedimensionalimmuneoncologymodelforhighthroughputtestingoftumoricidalactivity
AT hannahjgitschier novelthreedimensionalimmuneoncologymodelforhighthroughputtestingoftumoricidalactivity
AT annerossi novelthreedimensionalimmuneoncologymodelforhighthroughputtestingoftumoricidalactivity